Ryan Martins

Ryan Martins, listed as finance chief, appears in our data through filings on 89bio, Inc. shares, published by SEC (Form 4). We count 37 filings; the first trade dates from 5 February 2022 and the latest from 30 October 2025.

On the market, this insider has only sold: 6 sales, €326k in total. Other entries cover 29 share grants and 2 option exercises.

The record was last updated on 30 October 2025 with a share grant in 89bio, Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.